{
    "clinical_study": {
        "@rank": "31747", 
        "arm_group": {
            "arm_group_label": "Natural IVF Cycle", 
            "arm_group_type": "Experimental", 
            "description": "All patients will undergo a natural IVF cycle using trigger shots of Leuprolide Acetate(Lupron) and human chorionic gonadotropin (hCG) to ensure the patient surges."
        }, 
        "brief_summary": {
            "textblock": "Natural IVF study patients will undergo an IVF cycle with trigger shots of Lupron & hCG.\n      Patients will not be given any other stimulating medications during the cycle.  They will\n      have 2 uterine aspirations and an endometrial biopsy at designated times. The first uterine\n      aspiration will be randomized to one of four days (day before retrieval, day of retrieval,\n      day after retrieval or 2 days after retrieval).  The second uterine aspiration and\n      endometrial biopsy will be performed 6 days after retrieval. Any embryo(s) obtained will be\n      biopsied for Comprehensive Chromosome Screening (CCS) and frozen for use in a subsequent\n      thaw cycle."
        }, 
        "brief_title": "Natural Cycle In Vitro Fertilization", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Natural Cycle in Vitro Fertilization (IVF)", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ovulatory cycles every 39 days or less (natural cycle IVF cannot be performed in\n             someone who does  not have cycles)\n\n          -  Must be RMANJ patient and have completed all diagnostic screening at one of our RMANJ\n             locations.  All diagnostic screening is NOT covered under the study and must be\n             completed prior to being allowed to start the study cycle.\n\n        Exclusion Criteria:\n\n          -  Prior enrollment/attempt in this study\n\n          -  Requirement for surgical sperm extraction\n\n          -  Inability to assess ovaries via transvaginal ultrasound\n\n          -  Inability to tolerate vaginal examination"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "850", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01866618", 
            "org_study_id": "RMA-2013-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Natural IVF Cycle", 
                "description": "Patients will undergo two uterine aspirations and one endometrial biopsy. Any embryos obtained will undergo embryo biopsy for Comprehensive Chromosome Screening (CCS).  All embryos will be cryopreserved for subsequent use in a thaw cycle.", 
                "intervention_name": "Uterine Aspiration and Endometrial Biopsy/Embryo Biopsy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Natural IVF Cycle", 
                "intervention_name": "Leuprolide Acetate", 
                "intervention_type": "Drug", 
                "other_name": "Lupron 40U (2 mgs)given subcutaneously twice at 12 hour intervals to induce ovulation"
            }, 
            {
                "arm_group_label": "Natural IVF Cycle", 
                "intervention_name": "Human Chorionic Gonadotropin (hCG)", 
                "intervention_type": "Drug", 
                "other_name": "hCG 10,000U given subcutaneously once to induce ovulation"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Chorionic Gonadotropin", 
                "Leuprolide"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Natural", 
            "IVF Cycle"
        ], 
        "lastchanged_date": "July 9, 2013", 
        "link": {
            "description": "Reproductive Medicine Associates of New Jersey", 
            "url": "http://www.rmanj.com"
        }, 
        "location": {
            "contact": {
                "email": "clinicalresearchteam@rmanj.com", 
                "last_name": "Monica R Benson, BSN, RN", 
                "phone": "973-656-2841"
            }, 
            "contact_backup": {
                "email": "clinicalresearchteam@rmanj.com", 
                "last_name": "Janine M Casciello, BA", 
                "phone": "973-656-2841"
            }, 
            "facility": {
                "address": {
                    "city": "Basking Ridge", 
                    "country": "United States", 
                    "state": "New Jersey", 
                    "zip": "07920"
                }, 
                "name": "Reproductive Medicine Associates of New Jersey"
            }, 
            "investigator": {
                "last_name": "Richard T Scott, M.D., HCLD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Natural Cycle In Vitro Fertilization", 
        "other_outcome": {
            "description": "To examine the parameters of temporal embryonic development and the transcriptome of granulosa cells and follicular fluid. The embryos will be graded at standard time points to determine whether there are differences in in vitro development. Granulosa cells and follicular fluid will undergo gene expression analysis and compared to the gene expression profiles found in those specimens in stimulated cycles.", 
            "measure": "Temporal Embryonic Development", 
            "safety_issue": "No", 
            "time_frame": "1 Year"
        }, 
        "overall_contact": {
            "email": "clinicalresearchteam@rmanj.com", 
            "last_name": "Monica R Benson, BSN, RN", 
            "phone": "973-656-2841"
        }, 
        "overall_contact_backup": {
            "email": "clinicalresearchteam@rmanj.com", 
            "last_name": "Janine M Casciello, BA", 
            "phone": "973-656-2841"
        }, 
        "overall_official": {
            "affiliation": "Reproductive Medicine Associates of New Jersey", 
            "last_name": "Richard T Scott, M.D., HCLD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To examine the endometrium within the natural cycle in order to accurately characterize the differences in multiple aspects of endocrine and paracrine hormonal activity, the transcriptome of cells influencing oocyte maturation and changes in the endometrium.", 
            "measure": "Endometrial Changes", 
            "safety_issue": "No", 
            "time_frame": "1 Year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01866618"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "To examine aneuploidy rates in embryos from natural IVF cycles.", 
            "measure": "Aneuploidy Rates", 
            "safety_issue": "No", 
            "time_frame": "1 Year"
        }, 
        "source": "Reproductive Medicine Associates of New Jersey", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Reproductive Medicine Associates of New Jersey", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}